Andremacon Srl
Milan-based biotech company developing precision therapies for brain tumors and dual-use aerospace medicine technologies.
Last updated September 29, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Andremacon Srl is an Italian biotechnology company headquartered in Milan. According to its official website, it was established in Milan in 2014 by a team of researchers and entrepreneurs with the aim of transforming biological enigmas into groundbreaking medical solutions. The company positions itself at the intersection of precision medicine and aerospace medicine, pursuing what it describes as dual-use technologies and translational medicine approaches that can benefit healthcare both on Earth and in space. Andremacon's stated therapeutic focus areas include precision cancer therapy, brain tumors and glioblastoma, personalized therapies, and aerospace medicine. Its pipeline is described as encompassing dual-use technology, suggesting that research insights gained from space exploration are leveraged to advance terrestrial healthcare applications. The company presents itself as a research-driven enterprise dedicated to revolutionizing patient care and enhancing quality of life through scientific discovery. The company is registered as a Società a Responsabilità Limitata (Srl), the Italian limited liability company form, indicating it is a privately held entity. Its registered address is Viale Ortles 22/4, 20139 Milano, Italy. Contact is available via the email address info@andremacon.com listed on its website. As of the available evidence, Andremacon operates primarily from Italy and targets the broader European biotechnology and precision medicine landscape. While the company's public communications emphasize ambitious goals in oncology and aerospace medicine, detailed information about specific products, clinical programs, funding, or partnerships is not provided in the available sources. The company appears to be an early-stage or privately held research enterprise rather than a commercial-stage pharmaceutical manufacturer. Its dual focus on brain tumor precision therapy and aerospace medicine is a distinctive positioning within the Italian biotech sector.
History
Andremacon Srl was established in Milan, Italy, in 2014. According to the company's official website, it was founded by a visionary team of researchers and entrepreneurs. The founding team set out with a mission to transform biological enigmas into groundbreaking medical solutions, with a particular emphasis on precision medicine and the emerging field of aerospace medicine. From its base in Milan, the company has pursued research and development initiatives that bridge oncology and space medicine. Its stated focus on brain tumors and glioblastoma places it within the broader field of precision cancer therapy, while its interest in aerospace medicine reflects a growing international trend of applying spaceflight-related research to terrestrial healthcare challenges. The company describes its approach as leveraging the challenges and insights gained from space exploration to drive forward dual-use technologies and translational medicine approaches. The company operates as a privately held Italian limited liability company (Srl) and maintains its registered office at Viale Ortles 22/4 in Milan. Its public communications emphasize a dedication to revolutionizing patient care and enhancing life quality through scientific discovery. As of the available evidence, the company remains active and continues to promote its research focus areas through its official website.
- 2014
Andremacon Srl is established in Milan, Italy, by a team of researchers and entrepreneurs.
Products and positioning
A research-driven Italian biotech company focused on precision medicine for brain tumors and dual-use aerospace medicine technologies.
Precision cancer therapy
Therapeutic approaches focused on precision medicine for cancer.
Brain tumor and glioblastoma therapies
Therapies targeting brain tumors and glioblastoma.
Personalized therapies
Personalized therapeutic approaches.
Aerospace medicine
Dual-use technologies and translational medicine approaches derived from space exploration insights.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/andremacon-srl-italy · Editorial policy · How profiles are compiled